arrow
H

Helen M. Colhoun

hopital universitaire robert-debre - aphp
H指数:93
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial

司美格鲁肽和心血管风险降低:SELECT试验的中介分析

2026-09-230
OAAI
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Semaglutide对高危肝纤维化患者的肝纤维化和心脏结局的影响: 一项选择性随机试验的预设分析

2026-04-020
OAAI
Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort

2型糖尿病患者中的多药联用与潜在不适当处方:苏格兰糖尿病研究网络国家糖尿病队列分析

2025-11-010
OAAI
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial

司美格鲁肽和心血管结局与基线及体脂测量值变化的关系:SELECT试验的预先指定分析

2025-10-220
OAAI
The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

肥胖与慢性肾脏病的关系:肾脏病:改善全球预后(KDIGO)争议会议的结论

2025-10-090
PRE
Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes
2024-11-180
OAAI
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes ( vol 47, pg 1276, 2024)

监测胰岛自身抗体阳性前期3型糖尿病患者的共识指南 (第47卷,1276页,2024)

2024-09-060
PRE
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes (JUN, 10.1007/s00125-024-06205-5, 2024)

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南 (JUN,10.1007/s00125-024-06205-5,2024)

2024-09-040
OAAI
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials

使用低分辨队列评估低血糖暴露后的后果风险: 对胰岛素临床试验汇总数据的二次分析

2024-07-220
OAAI
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南

2024-06-243
OAAI
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南

2024-06-248
OA
Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial

SELECT试验中,司美鲁肽对超重或肥胖但无糖尿病患者血糖消退和进展的影响

2024-06-227
OAAI